Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1.

Sedman T, Rünkorg K, Krass M, Luuk H, Plaas M, Vasar E, Volke V.

J Diabetes Res. 2016;2016:9239530. doi: 10.1155/2016/9239530. Epub 2016 Mar 16.

2.

GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatment.

Krass M, Volke A, Rünkorg K, Wegener G, Lund S, Abildgaard A, Vasar E, Volke V.

Acta Neuropsychiatr. 2015 Feb;27(1):25-32. doi: 10.1017/neu.2014.36. Epub 2014 Dec 3.

PMID:
25469828
3.

Dual effect of nickel on L-arginine/nitric oxide system in RAW 264.7 macrophages.

Volke A, Rünkorg K, Wegener G, Vasar E, Volke V.

Int Immunopharmacol. 2013 Mar;15(3):511-6. doi: 10.1016/j.intimp.2013.01.019. Epub 2013 Feb 15.

PMID:
23415871
4.

Acute administration of GLP-1 receptor agonists induces hypolocomotion but not anxiety in mice.

Krass M, Rünkorg K, Vasar E, Volke V.

Acta Neuropsychiatr. 2012 Oct;24(5):296-300. doi: 10.1111/j.1601-5215.2012.00648.x. No abstract available.

PMID:
25286994
5.

Rimonabant attenuates amphetamine sensitisation in a CCK2 receptor-dependent manner.

Rünkorg K, Orav L, Kõks S, Matsui T, Volke V, Vasar E.

Behav Brain Res. 2012 Jan 1;226(1):335-9. doi: 10.1016/j.bbr.2011.09.005. Epub 2011 Sep 12.

PMID:
21925544
6.

Nitric oxide is involved in the regulation of marble-burying behavior.

Krass M, Rünkorg K, Wegener G, Volke V.

Neurosci Lett. 2010 Aug 9;480(1):55-8. doi: 10.1016/j.neulet.2010.06.002. Epub 2010 Jun 8.

PMID:
20553994
7.

Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.

Rünkorg K, Värv S, Matsui T, Kõks S, Vasar E.

Neurosci Lett. 2006 Oct 2;406(1-2):17-22. Epub 2006 Aug 17.

PMID:
16916582
8.

Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice.

Rünkorg K, Veraksits A, Kurrikoff K, Luuk H, Raud S, Abramov U, Matsui T, Bourin M, Kõks S, Vasar E.

Behav Brain Res. 2003 Sep 15;144(1-2):125-35.

PMID:
12946603
9.

Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice.

Raud S, Rünkorg K, Veraksits A, Reimets A, Nelovkov A, Abramov U, Matsui T, Bourin M, Volke V, Kõks S, Vasar E.

Psychopharmacology (Berl). 2003 Aug;168(4):417-25. Epub 2003 Apr 23.

PMID:
12709779
10.

Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors.

Veraksits A, Rünkorg K, Kurrikoff K, Raud S, Abramov U, Matsui T, Bourin M, Kõks S, Vasar E.

Psychopharmacology (Berl). 2003 Mar;166(2):168-75. Epub 2003 Jan 24.

PMID:
12545332
11.
12.

Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.

Kõks S, Volke V, Veraksits A, Rünkorg K, Sillat T, Abramov U, Bourin M, Huotari M, Männistö PT, Matsui T, Vasar E.

Psychopharmacology (Berl). 2001 Nov;158(2):198-204.

PMID:
11702094

Supplemental Content

Loading ...
Support Center